Skip to content
2000
Volume 5, Issue 2
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Pancreatic cancer is an exceptionally devastating and incurable disease, the treatment of which has largely been unsuccessful due to the higher resistance of pancreatic tumor cells to oncologic treatment. PDAC cells have accumulated different molecular mechanisms, which enable survival against cytotoxic therapies. Defects of the apoptosis pathway play a crucial role. For the last 10 years, many investigations were underway to get insights into the details of the anti-apoptotic mechanisms of PDAC cells. The present review provides a comprehensive description of the molecular signaling of the apoptotic pathway, an incentive on the potential pathogenetic role of different molecular defects on existing oncologic treatments and an appraisal of the most recent therapeutic strategies applied at a cell biochemical level.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/157339409788166760
2009-05-01
2025-05-24
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/157339409788166760
Loading

  • Article Type:
    Research Article
Keyword(s): Apoptosis pathway; pancreatic cancer; review; targeted therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test